Table 3.

Menopausal symptoms at pre-test, post-1-month, and post-3-months by group.

	Control (N=42)		Intervention (N=49)		p

Outcome variables	Mean⁺	SD	Mean	SD	Group	Time	Group^*Time
Symptom Distress
Physical symptoms^a
Pre-test	1.40	0.32	1.42	0.37	.76	.21	.08^*
Post 1 month	1.41	0.29	1.36	0.34
Post 3 months	1.42	0.27	1.31	0.32
Psychological symptoms^b
Pre-test	1.64	0.37	1.76	0.47	.39	.28	.05^**
Post 1 month	1.67	0.33	1.65	0.43
Post 3 months	1.71	0.29	1.55	0.38
Psychosomatic symptoms^c
Pre-test	1.67	0.47	1.82	0.66	.34	.13	.06^*
Post 1 month	1.69	0.42	1.67	0.56
Post 3 months	1.70	0.42	1.52	0.49
Total
Pre-test	1.57	0.33	1.66	0.45	.36	.098^*	.01^**
Post 1 month	1.59	0.31	1.57	0.41
Post 3 months	1.61	0.30	1.47	0.37
Symptom Frequency
Psychological symptoms^d (log transformed)
Pre-test	1.94	0.54	1.82	0.54	.40	.008^***	.89
Post 1 month	1.84	0.42	1.71	0.45
Post 3 months	1.73	0.37	1.59	0.43

SD = standard deviation/ All categories of symptoms were measured using the MSAS-SF.

⁺

Predicted means for individual outcomes by group and time.

Physical symptoms included ‘nausea,’ ‘vomiting,’ ‘shortness of breath,’ ‘sweats,’ ‘feeling bloated,’ ‘problems with urination,’ ‘diarrhea,’ ‘weight loss,’ ‘itching,’ ‘changes in skin,’ ‘constipation,’ ‘swelling of arms or legs,’ ‘numbness/tingling in hands/feet,’ ‘lack of appetite,’ and ‘pain.’

Psychological symptoms included ‘difficulty concentrating’ and ‘problems with sexual interest or activity.’

Psychosomatic symptoms included ‘difficulty sleeping’ and ‘dizziness.’

Psychological symptoms included ‘feeling sad,’ ‘worrying,’ ‘feeling irritable,’ and ‘feeling nervous.’

p < .10

^**

p < .05

^***

p < .01